Critical care nursing quarterly · 2007
Pharmacological treatment of heart failure.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quinn Beverly
Аннотация
This article provides an overview of heart failure (HF) and pharmacological treatment of systolic left ventricular dysfunction. The purpose of this article is to provide nurses the knowledge of current treatment recommendations and the Five Million Lives campaign sponsored by the National Institute of Healthcare Improvement. This initiative is a national campaign to protect 5 million patients from medical harm by promoting evidence-based standards of practice to improve the healthcare of Americans. HF has become part of this national initiative and the National Institute of Healthcare Improvement in conjunction with the American College of Cardiology/American Heart Association has implemented guidelines to improve the care of HF patients. Nurses would be expected to be familiar with these guidelines, as regulatory agencies will be using these guidelines as a benchmark to evaluate the quality of care provided to patients with this diagnosis.
Предметные рубрики MeSH
Adrenergic beta-AntagonistsAngiotensin IIAngiotensin-Converting Enzyme InhibitorsBenchmarkingCalcium Channel BlockersCardiotonic AgentsCritical CareDiureticsEvidence-Based MedicineHealth Planning GuidelinesHeart Failure, SystolicHumansMineralocorticoid Receptor AntagonistsNurse's RolePractice Guidelines as TopicQuality Indicators, Health CareTotal Quality ManagementVasodilator AgentsVentricular Dysfunction, Left